+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RAS interaction with PI3K p110α is required for tumor-induced angiogenesis

RAS interaction with PI3K p110α is required for tumor-induced angiogenesis

Journal of Clinical Investigation 124(8): 3601-3611

Direct interaction of RAS with the PI3K p110α subunit mediates RAS-driven tumor development: however, it is not clear how p110α/RAS-dependant signaling mediates interactions between tumors and host tissues. Here, using a murine tumor cell transfer model, we demonstrated that disruption of the interaction between RAS and p110α within host tissue reduced tumor growth and tumor-induced angiogenesis, leading to improved survival of tumor-bearing mice, even when this interaction was intact in the transferred tumor. Furthermore, functional interaction of RAS with p110α in host tissue was required for efficient establishment and growth of metastatic tumors. Inhibition of RAS and p110α interaction prevented proper VEGF-A and FGF-2 signaling, which are required for efficient angiogenesis. Additionally, disruption of the RAS and p110α interaction altered the nature of tumor-associated macrophages, inducing expression of markers typical for macrophage populations with reduced tumor-promoting capacity. Together, these results indicate that a functional RAS interaction with PI3K p110α in host tissue is required for the establishment of a growth-permissive environment for the tumor, particularly for tumor-induced angiogenesis. Targeting the interaction of RAS with PI3K has the potential to impair tumor formation by altering the tumor-host relationship, in addition to previously described tumor cell-autonomous effects.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333384

Download citation: RISBibTeXText

PMID: 25003191

DOI: 10.1172/JCI74134

Related references

Enhanced PI3K p110α signaling confers acquired lapatinib resistance that can be effectively reversed by a p110α-selective PI3K inhibitor. Molecular Cancer Therapeutics 13(1): 60-70, 2014

mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer. Science Translational Medicine 5(196): 196ra99-196ra99, 2014

Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis. Journal of Experimental Medicine 210(10): 1937-1945, 2013

Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2. Growth Factors 30(6): 367-384, 2013

Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-κB signaling. European Journal of Pharmacology 737: 57-69, 2015

BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models. Molecular Cancer Therapeutics 12(11): 2319-2330, 2014

DW09849, a selective phosphatidylinositol 3-kinase (PI3K) inhibitor, prevents PI3K signaling and preferentially inhibits proliferation of cells containing the oncogenic mutation p110α (H1047R). Journal of Pharmacology and Experimental Therapeutics 348(3): 432-441, 2014

BMP2-induced chemotaxis requires PI3K p55γ/p110α-dependent phosphatidylinositol (3,4,5)-triphosphate production and LL5β recruitment at the cytocortex. Bmc Biology 12(): 43-43, 2014

Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction. Circulation. Heart Failure 5(4): 523-534, 2012

Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription. Molecular Cancer 13: 209-209, 2015

BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway. Plos One 11(1): E0148133-E0148133, 2016

Requirement for interaction of PI3-kinase p110α with RAS in lung tumor maintenance. Cancer Cell 24(5): 617-630, 2014

A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis. Molecular Cancer Research 12(10): 1520-1531, 2015

Twist is required for thrombin-induced tumor angiogenesis and growth. Cancer Research 68(11): 4296-4302, 2008

Twist is required for thrombin-induced tumor angiogenesis as well as migration. 2007